Wednesday - November 18, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to LGM Pharma Solutions
November 18, 2026
WASHINGTON, Nov. 18 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to LGM Pharma Solutions LLC from its Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Prasad Raje, Chief Executive Officer, LGM Pharma Solutions, LLC, 6400 Congress Ave., Suite 1400, Boca Raton, FL 33487, United States

(b)(6)

Issuing Office: Center for Drug Evaluation and Research (CDER) . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products